edelfosine has been researched along with sri 62-834 in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 7 (77.78) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Workman, P | 1 |
Donaldson, J; Lohmeyer, M; Workman, P | 1 |
Bazill, GW; Dexter, TM | 1 |
Handley, DA; Happy, J; Houlihan, WJ; Jaeggi, C; Lee, ML; Munder, PG; Nemecek, GM; Winslow, CM | 1 |
Borel, JF; Chabannes, D; Kovarik, J | 1 |
Lohmeyer, M; Workman, P | 1 |
Croft, SL; Snowdon, D; Yardley, V | 1 |
Arthur, G; Bittman, R | 1 |
Civoli, F; Daniel, LW | 1 |
1 review(s) available for edelfosine and sri 62-834
Article | Year |
---|---|
The inhibition of cell signaling pathways by antitumor ether lipids.
Topics: Animals; Antineoplastic Agents; Calcium; Furans; Humans; Phospholipid Ethers; Phosphorylcholine; Protein Kinases; Receptors, Cell Surface; Signal Transduction | 1998 |
8 other study(ies) available for edelfosine and sri 62-834
Article | Year |
---|---|
Antitumor ether lipids: endocytosis as a determinant of cellular sensitivity.
Topics: Animals; Antineoplastic Agents; Drug Resistance; Endocytosis; Furans; Humans; Oncogenes; Phospholipid Ethers; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1991 |
Platelet-activating factor (PAF) antagonist WEB 2086 does not modulate the cytotoxicity of PAF or antitumour alkyl lysophospholipids ET-18-O-methyl and SRI 62-834 in HL-60 promyelocytic leukaemia cells.
Topics: Antineoplastic Agents; Azepines; Calcium; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Furans; Humans; Leukemia, Promyelocytic, Acute; Phospholipid Ethers; Platelet Activating Factor; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 1991 |
An antagonist to platelet activating factor counteracts the tumoricidal action of alkyl lysophospholipids.
Topics: Biological Transport; Cell Survival; Furans; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tumor Cells, Cultured | 1989 |
Antitumor activity of SRI 62-834, a cyclic ether analog of ET-18-OCH3.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Transformation, Neoplastic; Cytotoxins; Furans; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Phospholipid Ethers; Protein Kinase C; Receptors, Cell Surface; Receptors, Platelet-Derived Growth Factor; Tumor Cells, Cultured | 1987 |
Immunoregulation and drug treatment in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat.
Topics: Animals; Autoimmune Diseases; Concanavalin A; Corticosterone; Cyclosporine; Dexamethasone; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Furans; Guinea Pigs; Lymph Nodes; Lymphocyte Activation; Lysophosphatidylcholines; Multiple Sclerosis; Myelin Basic Protein; Phospholipid Ethers; Rats; Rats, Inbred Lew; Tuberculin | 1995 |
The role of intracellular free calcium mobilization in the mechanism of action of antitumour ether lipids SRI 62-834 and ET18-OMe.
Topics: Antineoplastic Agents; Calcium; Cell Membrane; Dose-Response Relationship, Drug; Furans; Humans; Phospholipid Ethers; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1993 |
The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei.
Topics: Animals; Antineoplastic Agents; Chagas Disease; Cricetinae; Female; Furans; Leishmania donovani; Leishmaniasis, Visceral; Lysophospholipids; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Phospholipid Ethers; Phosphorylcholine; Rats; Rats, Sprague-Dawley; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi; Trypanosomiasis, African | 1996 |
Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
Topics: Antineoplastic Agents; Cell Differentiation; Cell Division; Cell Survival; Culture Media, Serum-Free; Drug Resistance; Enzyme Activation; Furans; HL-60 Cells; Humans; Phospholipid Ethers; Phosphorylcholine; Protein Kinase C; Quaternary Ammonium Compounds; Structure-Activity Relationship; Tetradecanoylphorbol Acetate | 1998 |